176 related articles for article (PubMed ID: 36845683)
1. Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study.
Chi K; Zhou R; Luo Z; Zhao H; Jiang Y; He B; Li Y; Chen D; Feng M; Liang Y; Yang W; Liu R; Yao D; Lin X; Xu X
Front Oncol; 2023; 13():1096027. PubMed ID: 36845683
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Outcomes in the Patients With Primary Central Nervous System Lymphoma: A Multi-Registry Based Cohort Study of 4,038 Cases.
Qiu Z; Tang Y; Jiang Y; Su M; Wang X; Xu X; Chen Y
Front Oncol; 2021; 11():691038. PubMed ID: 34290986
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study.
Guan T; Qiu Z; Su M; Yang J; Tang Y; Jiang Y; Yao D; Lai Y; Li Y; Liu C
Front Oncol; 2021; 11():641955. PubMed ID: 34046345
[TBL] [Abstract][Full Text] [Related]
4. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
5. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
[TBL] [Abstract][Full Text] [Related]
6. Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century.
Bei LY; Shang CY; Wu JZ; Shen HR; Yin H; Liang JH; Zhang XY; Wang L; Li JY; Li Y; Xu W
Ann Hematol; 2024 May; 103(5):1675-1685. PubMed ID: 38228775
[TBL] [Abstract][Full Text] [Related]
7. Long-term risks of cardiovascular death among older patients with major hematological malignancies: a population-based cohort study from SEER database.
Zhang H; He M; Zhang P; Gao Y; Ouyang L; He X; Han N; Zhang J; Guan M; Feng Y; Li Y
Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38713156
[TBL] [Abstract][Full Text] [Related]
8. Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer.
Guan T; Jiang Y; Luo Z; Liang Y; Feng M; Lu Z; Yi M; Teng Y; Zhou R; Zeng L; Chi K; Ou C; Chen M
Age Ageing; 2023 May; 52(5):. PubMed ID: 37192506
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
10. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Early Mortality in Patients with Primary Central Nervous System Lymphoma: A Large-Cohort Retrospective Study.
Zhou X; Niu X; Li J; Zhang S; Yang W; Yang Y; Mao Q; Liu Y
World Neurosurg; 2020 Jun; 138():e905-e912. PubMed ID: 32251807
[TBL] [Abstract][Full Text] [Related]
12. Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.
Youn P; Milano MT; Constine LS; Travis LB
Cancer; 2014 Aug; 120(15):2334-42. PubMed ID: 24752471
[TBL] [Abstract][Full Text] [Related]
13. Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers.
Guan T; Monteiro O; Chen D; Luo Z; Chi K; Li Z; Liang Y; Lu Z; Jiang Y; Yang J; Lin W; Yi M; Zhang K; Ou C
J Adv Res; 2024 Mar; ():. PubMed ID: 38537701
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma in the United States, 1975-2017.
Lv C; Wang J; Zhou M; Xu JY; Chen B; Wan Y
Ther Adv Hematol; 2022; 13():20406207211066166. PubMed ID: 35096360
[TBL] [Abstract][Full Text] [Related]
15. Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study.
Farrall AL; Smith JR
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499081
[TBL] [Abstract][Full Text] [Related]
16. Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995-2016: A population-based SEER analysis.
Chen C; Sun P; Sun XQ; Chen SY; Hang Yang ; Wang Y; Li ZM
Hematol Oncol; 2023 Apr; 41(2):248-256. PubMed ID: 34472655
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma].
Song J; Liu H; Shen HL; Yue LZ; Yang XJ; Song WJ; Sun CY; Yu SZ; Ding K; Wang YH; Li LJ; Yu H; Shao YY; Wang CM; Yue SY; Fu R
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):917-922. PubMed ID: 35045653
[No Abstract] [Full Text] [Related]
18. Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.
Hellesnes R; Myklebust TÅ; Fosså SD; Bremnes RM; Karlsdottir Á; Kvammen Ø; Tandstad T; Wilsgaard T; Negaard HFS; Haugnes HS
J Clin Oncol; 2021 Nov; 39(32):3561-3573. PubMed ID: 34388002
[TBL] [Abstract][Full Text] [Related]
19. Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis.
Yang C; Ren X; Cui Y; Jiang H; Yu K; Li M; Zhao X; Zhu Q; Lin S
Ann Transl Med; 2021 Jul; 9(13):1055. PubMed ID: 34422967
[TBL] [Abstract][Full Text] [Related]
20. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
